Swift Biosciences

Develops and sells reagents for genetic testing and Next Generation Sequencing (NGS).

placeAnn Arbor, Michigan, United States calendar_todayFounded 2010 groups41 employees language swiftbiosci.com

Registered entities

Innovation

14 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,783 times.

YearFilings
20132
20146
20154
20165
20174
20183
20196
20206
20216
20225
20231
20241

Investor mix

5 investors on record; lead investors include Fletcher Spaght, Charter Capital Partners, Arboretum Ventures.

Investor typeCountShare
Venture capital240%
Bank & private debt120%
Other / undisclosed240%
Coming soon